What's new? Log in Free sign up

SI-BONE (SIBN)

Company Profile

Company profile

Ticker

SIBN

Exchange

Website

CEO

Ms. Laura A. Francis MBA

Incorporated

Location

Fiscal year end

Sector

Health Care and Social Assistance > Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

Industry (SIC)

Surgical & Medical Instruments & Apparatus

3M • Ares Capital • Becton, Dickinson and • Stryker • Boston Scientific • Solventum • Baxter International • Teleflex • Hercules Capital • ResMed ...

Former names

SI-Bone Inc.

SEC CIK

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

SI-BONE S.R.L. • SI-BONE Deutschland GmbH • SI-BONE UK LTD ...

IRS number

262216351

SIBN stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Latest filings (excl ownership)

View all

Registration of securities for employees

25 Feb 25

SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2024 and Issues 2025 Guidance

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2024

Quarterly report

12 Nov 24

SI-BONE, Inc. Reports Financial Results for the Third Quarter 2024 and Updates Guidance

Quarterly report

6 Aug 24

SI-BONE, Inc. Reports Financial Results for the Second Quarter 2024

Entry into a Material Definitive Agreement

Material Modifications to Rights of Security Holders

Transcripts

View all

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Latest ownership filings

View all

Anshul Maheshwari

ANTHONY J RECUPERO

Anshul Maheshwari

ANTHONY J RECUPERO

ANTHONY J RECUPERO

Anshul Maheshwari

Financial summary

Financial statements Chart SIBN financial data

Quarter (USD)	Dec 24	Sep 24	Jun 24	Mar 24
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 24	Dec 23	Dec 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	34.95 mm	34.95 mm	34.95 mm	34.95 mm	34.95 mm	34.95 mm
Cash burn (monthly)	(no burn)	(no burn)	1.83 mm	2.94 mm	(no burn)	1.04 mm
Cash used (since last report)	n/a	n/a	3.81 mm	6.11 mm	n/a	2.15 mm
Cash remaining	n/a	n/a	31.14 mm	28.84 mm	n/a	32.79 mm
Runway (months of cash)	n/a	n/a	17.0	9.8	n/a	31.7

Beta Read what these cash burn values mean

Financial data from SI-BONE earnings reports.

Institutional ownership, Q3 2024

SIBN institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	136	141	-3.5%
Opened positions	20	24	-16.7%
Closed positions	25	27	-7.4%
Increased positions	53	60	-11.7%
Reduced positions	37	38	-2.6%

13F shares	Current	Prev Q	Change
Total value	553.28 bn	522.19 bn	+6.0%
Total shares	46.72 mm	45.93 mm	+1.7%
Total puts	251.70 k	249.50 k	+0.9%
Total calls	266.40 k	274.70 k	-3.0%
Total put/call ratio	0.9	0.9	+4.0%

Largest owners	Shares	Value	Change
Brown Advisory	4.00 mm	$55.97 bn	-3.4%
BlackRock	3.89 mm	$54.40 bn	NEW
Orbimed Advisors	3.31 mm	$46.22 bn	+2.3%
Orbimed Capital	3.25 mm	$42.80 mm	+41.0%
Champlain Investment Partners	2.80 mm	$39.15 bn	+14.7%
Vanguard	2.42 mm	$33.81 bn	+0.1%
American Century Companies	2.14 mm	$29.94 bn	+7.8%
Granahan Investment Management	1.66 mm	$23.16 bn	-6.1%
Silvercrest Asset Management	1.60 mm	$22.41 bn	+24.2%
Arboretum Ventures IV	1.55 mm	$46.27 mm	0.0%

Largest transactions	Shares	Bought/sold	Change
BlackRock	3.89 mm	+3.89 mm	NEW
BLK BlackRock	0.00	-3.85 mm	EXIT
First Light Asset Management	1.53 mm	-947.07 k	-38.3%
Orbimed Capital	3.25 mm	+944.20 k	+41.0%
Kent Lake Capital	0.00	-800.00 k	EXIT
Harbor Capital Advisors	620.49 k	+428.11 k	+222.5%
Champlain Investment Partners	2.80 mm	+358.82 k	+14.7%
Silvercrest Asset Management	1.60 mm	+312.02 k	+24.2%
Kent Lake PR	300.00 k	+300.00 k	NEW
Millennium Management	0.00	-239.95 k	EXIT

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

SIBN insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
18 Feb 25	Dunn Jeffrey W	Common Stock	Sell	Dispose S	No	No	16.7706	1,619	27.15 k	15,191
18 Feb 25	Recupero Anthony J	Common Stock	Sell	Dispose S	No	No	16.3854	314	5.15 k	287,866
18 Feb 25	Recupero Anthony J	Common Stock	Sell	Dispose S	No	No	16.7186	1,304	21.80 k	288,180
18 Feb 25	Recupero Anthony J	Common Stock	Sell	Dispose S	No	No	16.7003	1,504	25.12 k	289,484
18 Feb 25	Recupero Anthony J	Common Stock	Sell	Dispose S	No	No	16.7494	2,126	35.61 k	290,988
18 Feb 25	Recupero Anthony J	Common Stock	Sell	Dispose S	No	No	16.9709	3,343	56.73 k	293,114
18 Feb 25	Recupero Anthony J	Common Stock	Sell	Dispose S	No	No	17.3682	940	16.33 k	296,457
18 Feb 25	Anshul Maheshwari	Common Stock	Sell	Dispose S	No	No	16.7356	1,167	19.53 k	273,604
18 Feb 25	Anshul Maheshwari	Common Stock	Sell	Dispose S	No	No	17.3456	524	9.09 k	274,771
18 Feb 25	Anshul Maheshwari	Common Stock	Sell	Dispose S	No	No	16.941	3,782	64.07 k	275,295

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro

Expert Outlook: SI-BONE Through The Eyes Of 5 Analysts

Citizens Capital Markets Reiterates Market Outperform on SI-BONE, Maintains $32 Price Target

Citizens Capital Markets analyst David Turkaly reiterates SI-BONE (NASDAQ:SIBN) with a Market Outperform and maintains $32 price target.

Truist Securities Reiterates Buy on SI-BONE, Raises Price Target to $22

Truist Securities analyst Samuel Brodovsky reiterates SI-BONE (NASDAQ:SIBN) with a Buy and raises the price target from $18 to $22.

Cantor Fitzgerald Reiterates Overweight on SI-BONE, Maintains $25 Price Target

Needham Maintains Buy on SI-BONE, Raises Price Target to $24

Press releases

From Benzinga Pro

SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2024 and Issues 2025 Guidance

SANTA CLARA, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving sacropelvic disorders, today reported financial results for the fourth quarter and full

Bruker Appoints Laura Francis to its Board of Directors

Bruker Corporation (NASDAQ:BRKR) today announced that its Board of Directors has appointed Laura Francis to serve on its board as an independent director, effective as of February 18, 2025. Ms. Francis is also expected

SI-BONE to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 24, 2025

SANTA CLARA, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results for the fourth

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.